Literature DB >> 19775771

A review of quality of life instruments used in liver transplantation.

Colleen L Jay1, Zeeshan Butt, Daniela P Ladner, Anton I Skaro, Michael M Abecassis.   

Abstract

With improvements in patient and graft survival after liver transplantation, recipient quality of life (QOL) has become an important focus of patient care and clinical outcomes research. To provide a better understanding of the instruments used to assess QOL in the adult liver transplant population, we conducted a systematic review of the MEDLINE database and Cochrane library. Our review identified 128 relevant articles utilizing more than 50 different QOL instruments. Generic health status instruments are the most commonly used, and among them the Medical Outcomes Study Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale (HADS), and the Beck Depression Inventory (BDI) are the most prevalent. Few studies (16%) included targeted, disease-specific instruments. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Quality of Life questionnaire, the Liver Disease Quality of Life questionnaire, and the Chronic Liver Disease questionnaire are the most frequently employed targeted instruments; however, these instruments have been designed to assess QOL in patients with chronic liver disease rather than patients after liver transplantation. The present review focuses on the psychometric properties of the existing QOL instruments and discusses their individual strengths and limitations in evaluating liver transplantation recipients. The lack of a gold-standard QOL instrument for liver transplant recipients is an impediment to cross-study comparisons. We conclude that the development of a QOL instrument specifically for liver transplant recipients will improve QOL assessment in this population leading to a more nuanced understanding of the factors that influence transplant recipients' well-being.

Entities:  

Mesh:

Year:  2009        PMID: 19775771      PMCID: PMC2761971          DOI: 10.1016/j.jhep.2009.07.010

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  76 in total

1.  Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant.

Authors:  A L Phillips; E L Walker; J E Martin; M R First; D W Hanto; J F Whiting
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Conversion to Neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life.

Authors:  R H Tolba; B Wrigge; U Machein; T Minor; J C Kalff; A Hirner; M Wolff
Journal:  Transplant Proc       Date:  2001 Nov-Dec       Impact factor: 1.066

3.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

Review 4.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

5.  Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system.

Authors:  David Cella; Cindy J Nowinski
Journal:  Arch Phys Med Rehabil       Date:  2002-12       Impact factor: 3.966

6.  Assessing health-related quality of life pre- and post-liver transplantation: a prospective multicenter study.

Authors:  Julie Ratcliffe; Louise Longworth; Tracey Young; Stirling Bryan; Andrew Burroughs; Martin Buxton
Journal:  Liver Transpl       Date:  2002-03       Impact factor: 5.799

7.  The relevance of anxiety, depression, and coping in patients after liver transplantation.

Authors:  Ralf Nickel; Andreas Wunsch; Ulrich T Egle; Ansgar W Lohse; Gerd Otto
Journal:  Liver Transpl       Date:  2002-01       Impact factor: 5.799

8.  Chronic renal failure after transplantation of a nonrenal organ.

Authors:  Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

Review 9.  Quality of life measurement: bibliographic study of patient assessed health outcome measures.

Authors:  Andrew Garratt; Louise Schmidt; Anne Mackintosh; Ray Fitzpatrick
Journal:  BMJ       Date:  2002-06-15

10.  Psychiatric morbidity and its recognition by doctors in patients with cancer.

Authors:  L Fallowfield; D Ratcliffe; V Jenkins; J Saul
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

View more
  32 in total

Review 1.  Psychosocial Challenges in Solid Organ Transplantation.

Authors:  Kristin Kuntz; Stephan R Weinland; Zeeshan Butt
Journal:  J Clin Psychol Med Settings       Date:  2015-09

Review 2.  Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research.

Authors:  Zeeshan Butt; Neehar D Parikh; Anton I Skaro; Daniela Ladner; David Cella
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

3.  Health-related quality of life and affective status in liver transplant recipients and patients on the waiting list with low MELD scores.

Authors:  Christian Benzing; Nicco Krezdorn; Julia Förster; Andreas Hinz; Felix Krenzien; Georgi Atanasov; Moritz Schmelzle; Hans-Michael Hau; Michael Bartels
Journal:  HPB (Oxford)       Date:  2016-04-20       Impact factor: 3.647

4.  Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.

Authors:  Mary Amanda Dew; Andrea F DiMartini; Daniela P Ladner; Mary Ann Simpson; Elizabeth A Pomfret; Brenda W Gillespie; Robert M Merion; Jarcy Zee; Abigail R Smith; Susan Holtzman; Averell H Sherker; Robert Weinrieb; Robert A Fisher; Jean C Emond; Chris E Freise; James R Burton; Zeeshan Butt
Journal:  Transplantation       Date:  2016-06       Impact factor: 4.939

Review 5.  Quality of life for donors after living donor liver transplantation: a review of the literature.

Authors:  Neehar D Parikh; Daniela Ladner; Michael Abecassis; Zeeshan Butt
Journal:  Liver Transpl       Date:  2010-12       Impact factor: 5.799

6.  Psychological Outcomes of Living Liver Donors From a Multicenter Prospective Study: Results From the Adult-to-Adult Living Donor Liver Transplantation Cohort Study2 (A2ALL-2).

Authors:  Z Butt; M A Dew; Q Liu; M A Simpson; A R Smith; J Zee; B W Gillespie; S E Abbey; D P Ladner; R Weinrieb; R A Fisher; S Hafliger; N Terrault; J Burton; A H Sherker; A DiMartini
Journal:  Am J Transplant       Date:  2017-01-03       Impact factor: 8.086

7.  Patient reported outcomes: looking beyond the label claim.

Authors:  Lynda C Doward; Ari Gnanasakthy; Mary G Baker
Journal:  Health Qual Life Outcomes       Date:  2010-08-20       Impact factor: 3.186

Review 8.  Quality of life after liver transplantation: State of the art.

Authors:  Louis Onghena; Wouter Develtere; Carine Poppe; Anja Geerts; Roberto Troisi; Aude Vanlander; Frederik Berrevoet; Xavier Rogiers; Hans Van Vlierberghe; Xavier Verhelst
Journal:  World J Hepatol       Date:  2016-06-28

9.  NUTORC-a transdisciplinary health services and outcomes research team in transplantation.

Authors:  Daniela P Ladner; Estella M Alonso; Zeeshan Butt; Juan Carlos Caicedo; David Cella; Amna Daud; John J Friedewald; Elisa J Gordon; Gordon B Hazen; Bing T Ho; Kathleen R Hoke; Jane L Holl; Michael G Ison; Raymond Kang; Sanjay Mehrotra; Luke B Preczewski; Olivia A Ross; Pamela H Sharaf; Anton I Skaro; Edward Wang; Michael S Wolf; Donna M Woods; Michael M Abecassis
Journal:  Transl Behav Med       Date:  2012-12       Impact factor: 3.046

10.  Fatigue, Pain, and Other Physical Symptoms of Living Liver Donors in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study.

Authors:  Zeeshan Butt; Andrea F DiMartini; Qian Liu; Mary Ann Simpson; Abigail R Smith; Jarcy Zee; Brenda W Gillespie; Susan Holtzman; Daniela Ladner; Kim Olthoff; Robert A Fisher; Silvia Hafliger; Chris E Freise; Mercedes Susan Mandell; Averell H Sherker; Mary Amanda Dew
Journal:  Liver Transpl       Date:  2018-09       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.